Indications And Dose
Peripheral vascular disease ▶BY MOUTH ▶Adult: 3 g daily in 2–3 divided doses; maximum 4 g per day
PDF page 269
Drug reference
Peripheral vascular disease ▶BY MOUTH ▶Adult: 3 g daily in 2–3 divided doses; maximum 4 g per day
PDF page 269
Acute phase of a cerebrovascular accident. recent myocardial infarction
PDF page 269
Cerebrovascular insufficiency. unstable angina
PDF page 269
NICE decisions ▶Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease (May 2011) NICE TA223 Inositol nicotinate is not recommended for the treatment of intermittent claudication in patients with peripheral arterial disease; patients currently receiving treatment should have the option to continue until they and their clinician consider it appropriate to stop. www.nice.org.uk/guidance/ta223 l LESS SUITABLE FOR PRESCRIBING Less suitable for prescribing.
PDF page 269
▶Uncommon Dizziness. flushing. headache. nausea. oedema. paraesthesia. postural hypotension. rash. syncope. vomiting ▶Frequency not known Myalgia
PDF page 269
No information available—manufacturer advises avoid unless potential benefit outweighs risk.
PDF page 269
There can be variation in the licensing of different medicines containing the same drug. Forms available from special-order manufacturers include: oral suspension Capsule ▶Solgar No-Flush Niacin (Solgar Vitamin and Herb) Inositol nicotinate 500 mg Solgar No-Flush Niacin 500mg capsules | 50 capsule s VASODILATORS › FLAVONOIDS
PDF page 269
3 g daily in 2–3 divided doses; maximum 4 g per
First-line fragment. Read the complete Indications and Dose section above.
PDF page 269